Global Health Policy Blog

CGD experts offer ideas and analysis on global health issues and how better policies can improve well-being for everyone. Also check out our Views from the Center blog and US Development Policy blog.

 

The Global Fund to Fight AIDS, TB, and Malaria: Performance and Vision

The Global Fund to Fight AIDS, Tuberculosis, and Malaria (GFATM) was established very quickly in 2001 in response to a widespread perception that a rapid scale-up in financing was critical in the fight against the three diseases. Since it began operations in January 2002, GFATM has made important progress. It has raised substantial funding and become the world’s largest donor for TB and malaria. 70% of the programs reaching the two-year renewal stage are showing solid results. Rwanda, for example, has put over 4,000 people on ARV treatment, more than double its program target, and GFATM programs in aggregate have financed ARV treatment for 130,000 people to date.

About Vaccines for Development

CGDImmunization is one of the safest ways to reduce disease and poverty in developing countries. But 3 million people die every year of vaccine-preventable diseases; and that will likely rise to 4.5 million when rotavirus and pneumococcus vaccines are available, if past experience is any guide. And progress towards vaccines suitable for HIV, malaria and tuberculosis is painfully slow.

How to win the AIDS battle

Smart generals study history. The lessons of battles past pro­vide valuable clues about how to win in the future. In the war against AIDS in the developing world we need to study how major successes have been achieved in health programs and how to apply those lessons today.

Solving the Real Vaccine Shortage

As the most fragile Americans line up for a dwindling supply of flu shots, many people are wondering why vaccines, arguably the most essential and cost-effective pharmaceutical products, seem to be one of the health system’s weakest links. Americans are discovering what people in the developing world have long known: on their own, markets fail to provide the right vaccines when and where they are needed most.

Pages

Global Health Policy Blog

Tags

Experts